Carbidopa And Levodopa Tablet
FDA Label NDC 60687-836

15 label sections · Submitted to the FDA by American Health Packaging · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by American Health Packaging for the product Carbidopa And Levodopa (NDC 60687-836). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, indications and usage, contraindications, warnings, precautions, adverse reactions, overdosage, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Packaging Information

American Health Packaging unit dose blisters (see How Supplied section) contain drug product from Teva Pharmaceuticals USA, Inc. as follows:
(25 mg/100 mg / 100 UD) NDC 60687-661-01 packaged from NDC 0093-9702
(25 mg/250 mg / 100 UD) NDC 60687-836-01 packaged from NDC 0093-9703

Distributed by:
American Health Packaging
Columbus, OH 43217

8466101/0224(F)

Package/Label Display Panel – Carton – 25 Mg/100 Mg

NDC 60687- 661-01

Carbidopa and
Levodopa Tablets, USP

25 mg/100 mg

100 Tablets (10 x 10)                 Rx Only

Each Tablet Contains:
Carbidopa, USP (anhydrous equivalent) .................................. 25 mg
Levodopa, USP .......................................................................100 mg

Usual Adult Dosage: See full prescribing information.

Store at 20° to 25°C (68° to 77°F); excursions permitted between
15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
Protect from light.

FOR YOUR PROTECTION: Do not use if blister is torn or broken.

The drug product contained in this package is from
NDC # 0093-9702, Teva Pharmaceuticals USA, Inc.

Distributed by: American Health Packaging, Columbus, Ohio 43217

766101
0466101/0224

Package/Label Display Panel – Blister – 25 Mg/100 Mg

Carbidopa and Levodopa
Tablet, USP

25 mg/100 mg

Package/Label Display Panel – Carton - 25 Mg/250 Mg

NDC 60687- 836-01

Carbidopa and
Levodopa
Tablets, USP

25 mg/250 mg

100 Tablets (10 x 10)                 Rx Only

Each Tablet Contains:
Carbidopa, USP (anhydrous equivalent) ..................................25 mg
Levodopa, USP ........................................................................250 mg

Usual Adult Dosage: See full prescribing information.

Store at 20° to 25°C (68° to 77°F); excursions permitted between
15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
Protect from light.

FOR YOUR PROTECTION: Do not use if blister is torn or broken.

The drug product contained in this package is from
NDC # 0093-9703, Teva Pharmaceuticals USA, Inc.

Distributed by: American Health Packaging, Columbus, Ohio 43217

783601
0483691/0224

Package/Label Display Panel – Blister - 25 Mg/250 Mg

Carbidopa and
Levodopa
Tablet, USP

25 mg/250 mg

* Please review the disclaimer below.